Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet

Shares of Jazz Pharmaceuticals (JAZZ) have gained 11.5% over the past four weeks to close the last trading session at $122.64, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$177.06 indicates a potential upside of 44.4%.The average comprises 18 short-term price targets ranging from a low of $120 to a high of$230, with a standard deviation of $31.55. While the lowest estimate i ...